Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sun Biopharma Appoints CFO

This article was originally published in Scrip

Executive Summary

Sun BioPharma, Inc., a company focused on pancreatic diseases, has appointed Scott Kellen vice-president of finance and chief financial officer (CFO) effective immediately. Kellen brings over 20 years of healthcare, corporate finance and capital markets experience to Sun Biopharma and joins the company from Kips Bay Medical, Inc., a medical device company, where he was chief operating officer and CFO. Previously, Kellen was director of finance at Transoma Medical, Inc., and corporate controller for ev3, Inc. during its IPO and follow-on offerings.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC029966

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel